化合物Fosciclopirox T9422
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1380539-06-9 | ¥6,180.00 | 询底价 |
2 mg | 1380539-06-9 | ¥491.00 | 询底价 |
25 mg | 1380539-06-9 | ¥2,890.00 | 询底价 |
5 mg | 1380539-06-9 | ¥828.00 | 询底价 |
1 mL | 1380539-06-9 | ¥913.00 | 询底价 |
10 mg | 1380539-06-9 | ¥1,390.00 | 询底价 |
50 mg | 1380539-06-9 | ¥4,330.00 | 询底价 |
1 mg | 1380539-06-9 | ¥348.00 | 询底价 |
500 mg | 1380539-06-9 | ¥12,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Fosciclopirox
描述: Fosciclopirox (CPX-POM) 利用靶向γ-分泌酶,抑制尿路上皮癌的生长。静脉给药后,它选择性地将活性代谢物 Ciclopirox 递送至整个尿路。Ciclopirox 在许多实体和血液恶性肿瘤中显示出抗癌活性。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (315.19 mM)
关键字: γ-secretase | Fosciclopirox | Gamma secretase | Inhibitor | inhibit
相关产品: BMS-983970 | CIA-1 hcl(452087-38-6 Free base) | FLI-06 | MRK-560 | IMR-1 | DAPT | Semagacestat | Legumain inhibitor 1 | LY900009 | IMR-1A
相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | Anti-Cancer Active Compound Library | Stem Cell Differentiation Compound Library | Anti-Alzheimer's Disease Compound Library | Bioactive Compound Library
化合物Fosciclopirox T9422信息由TargetMol中国为您提供,如您想了解更多关于化合物Fosciclopirox T9422报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途